Literature DB >> 11773093

Antigenic heterogeneity of the hepatitis C virus NS5A protein.

Xiao-Guang Dou1, Ganesh Talekar, Joy Chang, Xing Dai, Lixia Li, Maria-Teresa Bonafonte, Brian Holloway, Howard A Fields, Yury E Khudyakov.   

Abstract

The effect of sequence variability between different types of hepatitis C virus (HCV) on the antigenic properties of the NS5 protein was studied by using recombinant proteins. A strong antigenic region was identified within the HCV NS5A protein at amino acids 2212 to 2313. Forty-five unique sequences encompassing this region were selected from GenBank and were compared to each other. The results of this analysis showed that the primary structure of this strong antigenic region is highly variable. Percent homology between different genotype sequences varied from 40.4 to 72.5%. Thirteen representative sequences from all six HCV genotypes were selected to design synthetic genes coding for this antigenic region. These genes were assembled by PCR from synthetic oligonucleotides and expressed in Escherichia coli as hybrid proteins with glutathione S-transferase. All 13 fusion proteins were purified from bacterial lysates and used to test a panel of anti-HCV positive sera (n = 91) obtained from patients infected with HCV genotypes 1 through 6. All but two proteins immunoreacted with 62 to 93% of HCV anti-NS5-positive serum samples. Although a variable degree of genotype-specific antigenic reactivity was detected, only one protein demonstrated a noticeable preference to immunoreact with antibodies against the homologous HCV genotype. On the other hand, closely related proteins derived from the same subtype or genotype immunoreacted with significantly different efficiency with HCV antibodies. Thus, sequence variability has a profound effect on the antigenic properties of the NS5A immunodominant regions. This observation should be taken into consideration in the development of diagnostic tests for the efficient detection of anti-HCV activity in serum specimens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773093      PMCID: PMC120141          DOI: 10.1128/JCM.40.1.61-67.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.

Authors:  L A Pereboeva; A V Pereboev; L F Wang; G E Morris
Journal:  J Med Virol       Date:  2000-02       Impact factor: 2.327

2.  Significance of NS3 and NS5 antigens in screening for HCV antibody.

Authors:  K Vernelen; H Claeys; H Verhaert; A Volckaerts; C Vermylen
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

3.  Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.

Authors:  J C Chang; C Seidel; B Ofenloch; D L Jue; H A Fields; Y E Khudyakov
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

4.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

5.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 6.  The detection, transmission, and outcome of hepatitis C virus infection.

Authors:  M J Alter
Journal:  Infect Agents Dis       Date:  1993-06

7.  Antibodies to a putative hepatitis C virus polyprotein in Japanese patients with chronic liver disease.

Authors:  N Yuki; N Hayashi; A Kasahara; H Hagiwara; K Ueda; H Fusamoto; T Kamada
Journal:  J Med Virol       Date:  1992-10       Impact factor: 2.327

8.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

Authors:  R D Aach; C E Stevens; F B Hollinger; J W Mosley; D A Peterson; P E Taylor; R G Johnson; L H Barbosa; G J Nemo
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

9.  Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.

Authors:  J M Barrera; M Bruguera; M G Ercilla; J M Sánchez-Tapias; M P Gil; J Costa; A Gelabert; J Rodés; R Castillo
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

10.  Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.

Authors:  F McOmish; S W Chan; B C Dow; J Gillon; W D Frame; R J Crawford; P L Yap; E A Follett; P Simmonds
Journal:  Transfusion       Date:  1993-01       Impact factor: 3.157

View more
  1 in total

1.  Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus.

Authors:  Charlotte Hedskog; Krishna Chodavarapu; Karin S Ku; Simin Xu; Ross Martin; Michael D Miller; Hongmei Mo; Evguenia Svarovskaia
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.